Synthesis and Characterization of Self-Assembling Amphiphiles for a Targeted Drug Delivery System to Treat Pancreatic and Colon Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer

  2012cited by this paper
• Diversity-oriented synthesis of macrocyclic peptidomimetics

  2011cited by this paper
• Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanism.

  2011cited by this paper
• Aqueous self-assembly of L-lysine-based amphiphiles into 1D n-type nanotubes.

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

  2011cited by this paper
• Enzyme‐instructed self‐assembly of peptide derivatives to form nanofibers and hydrogels

  2010cited by this paper
• Nanoparticles for Cancer Detection and Therapy

  2010cited by this paper
• Amphiphilic self-assembly of an n-type nanotube.

  2010cited by this paper
• A facile system for genetic incorporation of two different noncanonical amino acids into one protein in Escherichia coli.

  2010cited by this paper
• Self-assembly of 1-D n-type nanostructures based on naphthalene diimide-appended dipeptides.

  2009cited by this paper
• Controllable peptide-dendron self-assembly: interconversion of nanotubes and fibrillar nanostructures.

  2009cited by this paper
• A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.

  2009cited by this paper
• Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.

  2009cited by this paper
• Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft Models

  2009cited by this paper
• Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.

  2008cited by this paper
• Concept and clinical evaluation of carrier-mediated anticancer agents.

  2008cited by this paper
• 727 POSTER PEGylation governs the disposition and metabolism of irinotecan following administration of a novel PEG–Irinotecan conjugate

  2007cited by this paper
• Toxic Potential of Materials at the Nanolevel

  2006cited by this paper
• Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models

  2006cited by this paper
• Pancreatic cancer: surgery alone is not sufficient

  2006cited by this paper
• Anion-directed self-assembly of coordination polymer into tunable secondary structure.

  2004cited by this paper
• Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells

  2003cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Pancreatic cancer: a review of emerging therapies.

  2000cited by this paper
• [Chemotherapy for adenocarcinoma of the pancreas].

  1997cited by this paper
• Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

  1994cited by this paper
• The origin of cancer and the role of nutrient supply: a new perspective.

  1988cited by this paper

• No citing papers are available for this paper.